These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 21537073)

  • 1. Impact of lamivudine treatment in late pregnancy on the development of the foetal immune response to hepatitis B virus: a meta-analysis in R with the metafor package.
    Zhao P; Zhao Y; Du M; Chen X; Lu Y
    Trans R Soc Trop Med Hyg; 2024 Apr; 118(4):264-272. PubMed ID: 38048279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant.
    Bzowej NH
    Curr Hepat Rep; 2012 Jun; 11(2):82-89. PubMed ID: 22707918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population-based study.
    Kochaksaraei GS; Yang F; Seow CH; Barkema HW; Coffin CS; Shaheen AA
    J Viral Hepat; 2024 May; ():. PubMed ID: 38771315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis B and C in HIV-exposed South African infants.
    Tamandjou Tchuem C; Cotton MF; Nel E; Tedder R; Preiser W; Violari A; Bobat R; Hovind L; Aaron L; Montepiedra G; Mitchell C; Andersson MI
    BMC Pediatr; 2020 Dec; 20(1):563. PubMed ID: 33357228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine's efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis.
    Khalighinejad P; Alavian SM; Fesharaki MG; Jalilianhasanpour R
    Turk J Gastroenterol; 2019 Jan; 30(1):66-74. PubMed ID: 30475212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.
    Tan Z; Yin Y; Zhou J; Wu L; Xu C; Hou H
    Medicine (Baltimore); 2016 Oct; 95(40):e4847. PubMed ID: 27749537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of mother to child transmission of hepatitis B].
    El Agheb MO; Grange JD
    Pan Afr Med J; 2015; 20():316. PubMed ID: 26175807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.
    Zhang L; Gui X; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Zhang L; Zhang H; Liu X
    Eur J Pediatr; 2014 Sep; 173(9):1161-8. PubMed ID: 24699981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus.
    Chen X; Chen J; Wen J; Xu C; Zhang S; Zhou YH; Hu Y
    PLoS One; 2013; 8(1):e55303. PubMed ID: 23383145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.
    Pan CQ; Yi W; Liu M; Wan G; Hu YH; Zhou MF
    J Viral Hepat; 2017 Mar; 24(3):246-252. PubMed ID: 28025872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.
    Brown RS; McMahon BJ; Lok AS; Wong JB; Ahmed AT; Mouchli MA; Wang Z; Prokop LJ; Murad MH; Mohammed K
    Hepatology; 2016 Jan; 63(1):319-33. PubMed ID: 26565396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants.
    Köse S; Türken M; Devrim I; Taner C
    J Infect Dev Ctries; 2011 Apr; 5(4):303-6. PubMed ID: 21537073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
    Jiang HX; Han GR; Wang CM; Ji Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
    Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
    J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.